Rituximab therapy in adults with steroid-dependent nephrotic syndrome

Introduction Patients with steroid-dependent nephrotic syndrome (SDNS) suffer frequent relapse with adverse effects caused by long-term prednisolone treatment. Recently, the chimeric monoclonal antibody against the protein CD20 (rituximab – RTX) was observed to be efficacious and safe in the treatme...

Descripció completa

Dades bibliogràfiques

Autors principals:	Hongzhen Zhong, Hong-Yan Li, Tianbiao Zhou, Wenjuan Weng
Format:	Artigo
Idioma:	Inglês
Publicat:	Termedia Publishing House 2019-10-01
Col·lecció:	Archives of Medical Science
Matèries:	steroid-dependent nephrotic syndrome rituximab efficacy safety
Accés en línia:	https://www.archivesofmedicalscience.com/Rituximab-therapy-in-adults-with-steroid-dependent-nephrotic-syndrome,111931,0,2.html
Etiquetes:	Afegir etiqueta Sense etiquetes, Sigues el primer a etiquetar aquest registre!